American Cancer Society guidelines for the early detection of cancer: Update of early detection guidelines for prostate, colorectal, and endometrial cancers - ALSO: Update 2001 - Testing for early lung cancer detection

被引:601
作者
Smith, RA [1 ]
von Eschenbach, AC
Wender, R
Levin, B
Byers, T
Rothenberger, D
Brooks, D
Creasman, W
Cohen, C
Runowicz, C
Saslow, D
Cokkinides, V
Eyre, H
机构
[1] Amer Canc Soc, Dept Canc Control, Atlanta, GA 30329 USA
[2] Univ Texas, MD Anderson Canc Ctr, Program Ctr Genitourinary Canc, Houston, TX 77030 USA
[3] Thomas Jefferson Univ, Dept Family Med, Philadelphia, PA 19107 USA
[4] Univ Colorado, Sch Med, Dept Prevent Med & Biometr, Denver, CO USA
[5] Univ Minnesota, Ctr Canc, Div Colon & Rectal Surg, Minneapolis, MN USA
[6] Univ Minnesota, Ctr Canc, Dept Surg Oncol, Minneapolis, MN USA
[7] Med Univ S Carolina, Charleston, SC 29425 USA
[8] Mt Sinai Med Ctr, New York, NY 10029 USA
[9] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Bronx, NY 10467 USA
[10] Amer Canc Soc, Dept Epidemiol & Res Surveillance, Atlanta, GA 30329 USA
关键词
D O I
10.3322/canjclin.51.1.38
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Updates to the American Cancer Society (ACS) guidelines regarding screening for the early detection of prostate, colorectal, and endometrial cancers, based on the recommendations of recent ACS workshops, are presented, Additionally, the authors review the "cancer-related check-up, clinical encounters that provide case-finding and health counseling opportunities. Finally, the ACS is issuing an updated narrative related to testing for early lung cancer detection for clinicians and individuals at high risk of lung cancer in light of emerging data on new imaging technologies. Although it is likely that current screening protocols will be supplanted in the Mure by newer, more effective technologies, the establishment of an organized and systematic approach to early cancer detection would lead to greater utilization of existing technology and greater progress in cancer control.
引用
收藏
页码:38 / 75
页数:38
相关论文
共 192 条
[1]  
Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO
[2]  
2-C
[3]   Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome [J].
Aarnio, M ;
Mecklin, JP ;
Aaltonen, LA ;
NystromLahti, M ;
Jarvinen, HJ .
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (06) :430-433
[4]   Molecular stool screening for colorectal cancer - Using DNA markers may be beneficial, but large scale evaluation is needed [J].
Ahlquist, DA .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7256) :254-255
[5]   Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panel [J].
Ahlquist, DA ;
Skoletsky, JE ;
Boynton, KA ;
Harrington, JJ ;
Mahoney, DW ;
Pierceall, WE ;
Thibodeau, SN ;
Shuber, AP .
GASTROENTEROLOGY, 2000, 119 (05) :1219-1227
[6]   IS THE RISK OF CANCER OF THE CORPUS-UTERI REDUCED BY A RECENT PREGNANCY - A PROSPECTIVE-STUDY OF 765,756 NORWEGIAN WOMEN [J].
ALBREKTSEN, G ;
HEUCH, I ;
TRETLI, S ;
KVALE, G .
INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (04) :485-490
[7]  
*AM AC FAM PHYS, 2000, AG CHARTS PER HLTH E
[8]  
*AM CANC SOC, 1993, AM CANC SOC GUID CAN
[9]  
*AM CANC SOC, 1999, CANC RISK REP PREV C
[10]  
*AM CANC SOC, 1998, SUMM REP AM CANC SOC